Trial Profile
Preventive therapy for multidrug-resistant tuberculosis: a multicentre clincal trial.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2014
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary) ; Ethambutol; Pyrazinamide
- Indications Tuberculosis
- Focus Adverse reactions
- Acronyms MOXEP
- 05 Jun 2014 New trial record